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Abstract
Objectives To measure the effectiveness and cost effectiveness
of providing care in a chest pain observation unit compared
with routine care for patients with acute, undifferentiated chest
pain.
Design Cluster randomised controlled trial, with 442 days
randomised to the chest pain observation unit or routine care,
and cost effectiveness analysis from a health service costing
perspective.
Setting The emergency department at the Northern General
Hospital, Sheffield, United Kingdom.
Participants 972 patients with acute, undifferentiated chest
pain (479 attending on days when care was delivered in the
chest pain observation unit, 493 on days of routine care)
followed up until six months after initial attendance.
Main outcome measures The proportion of participants
admitted to hospital, the proportion with acute coronary
syndrome sent home inappropriately, major adverse cardiac
events over six months, health utility, hospital reattendance and
readmission, and costs per patient to the health service.
Results Use of a chest pain observation unit reduced the
proportion of patients admitted from 54% to 37% (difference
17%, odds ratio 0.50, 95% confidence interval 0.39 to 0.65,
P < 0.001) and the proportion discharged with acute coronary
syndrome from 14% to 6% (8%, –7% to 23%, P = 0.264). Rates
of cardiac event were unchanged. Care in the chest pain
observation unit was associated with improved health utility
during follow up (0.0137 quality adjusted life years gained, 95%
confidence interval 0.0030 to 0.0254, P = 0.022) and a saving of
£78 per patient (–£56 to £210, P = 0.252).
Conclusions Care in a chest pain observation unit can improve
outcomes and may reduce costs to the health service. It seems
to be more effective and more cost effective than routine care.
Introduction
Patients with acute chest pain present a common challenge to
acute medical services. Rapid and accurate assessment for an
acute coronary syndrome is essential,1 yet clinical assessment,
electrocardiography, and chest radiography have well recognised
limitations.2 Many patients are therefore admitted to hospital for
observation.3 Despite this, inadvertent discharge of patients with
possible acute coronary syndrome remains common.4 5
The concept of the chest pain observation unit has been
developed to address these problems.6 7 Patients with chest pain
for which no definite diagnosis has been made after clinical
assessment, electrocardiogram, and chest radiograph, receive
several hours of observation, electrocardiography, and measure-
ment of biochemical cardiac markers, followed by provocative
cardiac testing where appropriate. Patients with positive tests are
admitted to hospital, whereas those with negative tests may safely
be discharged home. This approach aims to improve care by
providing a more rigorous diagnostic assessment while reducing
costs to the health service by avoiding unnecessary admissions to
hospital.
We aimed to evaluate the effectiveness and cost effectiveness
of care in a chest pain observation unit. The specific objectives
were to measure the effect of care in the chest pain observation
unit on admission to hospital for undifferentiated chest pain,
inappropriate discharge home with acute coronary syndrome,
health utility, major adverse cardiac events, and reattendance at
and readmission to hospital; and to measure the cost
effectiveness of care in the chest pain observation unit compared
with routine care.
Methods
We undertook a randomised controlled trial comparing care in a
chest pain observation unit with routine care in the emergency
department of the Northern General Hospital in Sheffield,
United Kingdom. The department provides emergency services
for adults to the 530 000 population of Sheffield and is attended
by some 90 000 adults per year. From 5 February 2001 to 5 May
2002 we randomised days to either care in the chest pain obser-
vation unit or routine care, according to a block randomisation
schedule. Research staff and chest pain nurses had access to this
schedule, but other staff, general practitioners, and patients did
not. Patients presenting on days when the chest pain observation
unit was open were managed according to the unit’s protocols;
patients presenting on other days received routine care.
Intervention: chest pain observation unit
The chest pain observation unit was based in the emergency
department and consisted of two monitored bays and an
adjacent area for an unlimited number of unmonitored patients.
It was staffed by three experienced (G grade) chest pain nurses
with a background in either coronary care or emergency
medicine, who had received additional training in supervising
exercise treadmill tests.8 Together they covered the chest pain
observation unit from 9 00 am to 9 00 pmMonday to Friday, and
10 00 am to 6 00 pm at weekends. Patients attending outside
these hours could be admitted and complete their assessment
the following day. Middle grade emergency department staff
provided medical cover.
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We selected patients according to validated clinical
predictors9 10 and offered assessment consisting of two to six
hours of ST segment monitoring11 and hourly electrocardiogra-
phy, measurement of biochemical cardiac markers (CK-
MB(mass) on arrival and at least two hours later12 and of
troponin T at least six hours after onset of symptoms13) and exer-
cise treadmill testing.14 Patients with positive tests were admitted;
those with negative tests were discharged.
Control: routine care
Patients were managed at the discretion of the emergency
department medical staff, without use of the chest pain observa-
tion unit or assistance from the chest pain nurses. The
emergency department has access to CK-MB(mass) and
troponin T assays with a turnaround time of one hour. If patients
required observation or further testing they were admitted to
hospital.
Reception staff (who were unaware of the randomisation
schedule) recorded the presenting complaint of all patients
attending the emergency department. The chest pain nurses
then identified all patients presenting with a specific list of chest
pain related complaints (prospectively when they were on duty
and retrospectively, from a computer generated list, at other
times), and then excluded patients with changes to their electro-
cardiogram that were diagnostic for acute coronary syndrome,
clinically diagnosed unstable angina, comorbidity, or a serious
alternative cause for chest pain; and patients who were younger
than 25, with a negligible risk of coronary heart disease, or who
were unable to take part in the trial or provide consent. Eligible
patients were asked to provide written, informed consent to sub-
sequent follow up. Those who declined to consent were still
managed according to availability of the chest pain observation
unit but were not followed up.
Follow up consisted of a clinic run by the chest pain nurses
some 48 hours after initial attendance, at which an electrocardio-
gram was recorded and troponin T concentration measured.
Postal questionnaires for completion by each patient were
provided at 48 hours and one month, for return to the medical
care research unit. At six months we searched the hospital com-
puter system for evidence of attendance at the emergency
department or admission to hospital. We retrieved and reviewed
relevant case notes. Finally, a research assistant telephoned each
participant to collect further follow up information.
The primary outcome was the proportion of participants
admitted to hospital. A key secondary outcome was the
proportion of patients with acute coronary syndrome who were
discharged home inappropriately. We defined acute coronary
syndrome as a raised concentration of troponin T ( > 0.03
ng/ml) at follow up. Patients with raised troponin T
concentrations are at increased risk of adverse events15 and ben-
efit from treatment that is currently provided for inpatients.16
Other outcome measures were the major adverse cardiac event
rate (cardiac death, life threatening arrhythmia, heart failure
requiring admission to hospital, non-fatal myocardial infarction,
or revascularisation procedure); health utility, as measured by the
EQ-5D questionnaire at two days, one month, and six months;
and reattendance at or readmission to hospital.
Cost effectiveness analysis
We identified and measured costs from a health service perspec-
tive. Over the following six months we measured use of resources
related to the initial attendance: care in the emergency
department, initial admission to hospital, reviews of outpatients,
investigations related to chest pain, reattendances, readmissions,
and cardiac procedures. We used direct observation of a
subgroup of patients to measure in detail the use of resources
during the initial six hours of care. We measured subsequent use
of resources at aggregate level.
To value resources we used UK national unit costs where
available17 18 and local costs elsewhere. We used data from the
finance department of Sheffield’s teaching hospitals to value staff
time, with methods outlined by the personal social services
research unit.18 We used local unit costs to value overheads, inpa-
tient hospital stays, blood tests, and radiographs. We used
national estimates to value other diagnostic tests (such as
echocardiography), outpatient reviews, attendances at the emer-
gency department, and cardiac procedures.17 18
We used EQ-5D and six month survival data to measure out-
comes. We calculated the area under the curve for health utility
to generate estimates of quality adjusted life years (QALYs)
accrued over six months. We used regression to impute missing
data and undertook a sensitivity analysis to explore the effect of
using the following methods for handling missing data:
exclusion of patients with missing data, simple mean imputation,
and random value imputation from patients with data. We com-
pared the costs and outcomes in the chest pain observation unit
with routine care and estimated the incremental cost
effectiveness of care in the chest pain observation unit.
Statistical analysis
A sample size of 988 was required to detect a difference of 7.5%
in the proportion admitted (= 0.05, = 0.80). We did not adjust
this estimate for clustering because the small cluster size and
large number of clusters indicated important design effect, we
had no strong theoretical reason to suspect substantial
clustering, and pilot data showed no measurable evidence of
clustering. The principal analysis used multilevel random effects
modelling (Stata, version 7.0) to adjust for clustering by day of
week, but not confounding. Secondary analysis adjusted for
potential confounding by age, sex, and past history of coronary
heart disease (determined a priori to be potentially important
prognostic factors) and any other characteristic that either
showed significant baseline imbalance (P < 0.05) or predicted
outcome. We derived cost effectiveness estimates from 1000
bootstrap estimates of the difference between the mean costs
and QALYs accrued after care in the chest pain observation unit
and routine care.
Results
We randomised 442 days in equal numbers (221 each) to care in
the chest pain observation unit and routine care. Screening
identified 6957 attendances with chest pain or a related
complaint (6% of all attendances to the emergency department).
Of these 1631 (23.5%) were potentially eligible for care in the
chest pain observation unit, 1118 (16.1%) were asked to partici-
pate, and 972 (14%) agreed. Figure 1 shows the CONSORT dia-
gram, and table 1 shows the application of exclusion criteria. The
study groups are outlined in table 2. Source of referral, smoking
status, and electrocardiogram at presentation showed significant
baseline imbalance between the study groups. Hence adjusted
analyses included these covariates, along with age, sex, and past
history of coronary heart disease.
The proportion admitted was 36.7% (176/479) of patients
receiving care in the chest pain observation unit and 53.8%
(265/493) receiving routine care (odds ratio 0.5, 95% confidence
interval 0.39 to 0.65, P < 0.001, intraclass correlation coef-
ficient = 0.001). Adjustment for confounding did not alter this
result (adjusted odds ratio 0.49, 0.36 to 0.65, P < 0.001). The 146
patients who were eligible for the study but declined to consent
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were also less likely to be admitted if they attended when the
chest pain observation unit was open (22.1% v 40.0%, odds ratio
0.43, P = 0.02).
Seventy patients had a raised concentration of troponin T at
follow up (mean concentration 0.65 ng/ml, median concentra-
tion 0.29 ng/ml, 57/70 (81.4%) > 0.1 ng/ml). Seven (10%) had
been discharged home: 2/34 (5.9%) who received care in the
chest pain observation unit and 5/36 (13.9%) who received rou-
tine care (difference 8.0%, − 7.3% to 23.4%, P = 0.264).
Two participants in each group died during follow up, two
from cardiac causes and two from non-cardiac causes. Nine other
patients had serious, but non-fatal, cardiac events during follow
up (all non-fatal myocardial infarction), four from the group
receiving care in the chest pain observation unit and five from
the group receiving routine care. Another 24 participants
underwent a revascularisation procedure during follow up,
which makes a total of 35 patients categorised as having a major
adverse cardiac event during follow up (3.6%): 18 (3.8%) from
the group receiving care in the chest pain observation unit and
17 (3.4%) from the group receiving routine care (difference
0.4%, − 2.0 to 2.7, P = 0.796).
Table 3 shows the EQ-5D scores. The mean area under the
curve for health utility was 0.3936 QALYs after care in the chest
pain observation unit and 0.3799 QALYs after routine care (dif-
ference 0.0137 QALYs, 95% confidence interval 0.0030 to
0.0254, P = 0.022; adjusted difference 0.0143 QALYs, 0.0031 to
0.0255, P = 0.012). The intraclass correlation coefficient was zero
for all health utility analyses. The results were robust to sensitiv-
ity analysis according to the method of handling missing data.
Over the six month follow up period, 61 participants (12.7%)
in the group receiving care in the chest pain observation unit
and 85 (17.2%) in the group receiving routine care reattended
the emergency department (odds ratio for reattendance after
chest pain observation unit care 0.65, P = 0.05; adjusted odds
ratio 0.66, P = 0.061). Over the same time, 37 participants (7.7%)
in the chest pain observation unit group and 52 (10.5%) in the
routine care group were readmitted to hospital (odds ratio 0.67,
P = 0.122; adjusted odds ratio 0.65, P = 0.126).
The mean cost per patient for chest pain related care over six
months was £478 for the chest pain observation unit group and
£556 for the routine care group (difference £78 per patient,
− £56 to £210, P = 0.252; intraclass correlation coef-
ficient = 0.046; adjusted difference £53 per patient, − £88 to
+£194, P = 0.462). Table 4 shows the breakdown of resource use
for each group and table 5 shows the breakdown of costs. Higher
initial costs for care in the chest pain observation unit were offset
by lower costs for hospital admission and follow up.
Days randomised (n=442)
Days, routine care (n=221)Days, chest pain
observation unit care (n=221)
Eligible (n=563, 16.1%)Eligible (n=555, 16.1%)
Attendances with
chest pain (n=3506)
Attendances with
chest pain (n=3451)
Consented (n=493, 87.6% of eligible)Consented (n=479, 86.3% of eligible)
Attended review
(n=432, 87.6% of consented)
Attended review
(n=419, 87.5% of consented)
Returned two day questionnaire
(n=355, 72.0% of consented)
Returned two day questionnaire
(n=362, 75.6% of consented)
Returned one month questionnaire
(n=337, 68.4% of consented)
Returned one month questionnaire
(n=342, 71.4% of consented)
Replied to six month telephone call
(n=343, 69.6% of consented)
Replied to six month telephone call
(n=333, 69.5% of consented)
Fig 1 Flow of participants through the trial
Table 1 Application of each exclusion criterion by group. Values are numbers (percentages) unless otherwise indicated
All patients (n=6957)
Patients attending
Odds ratio
Chest pain observation unit days
(n=3451) Routine care days (n=3506)
Changes to the electrocardiogram that are
diagnostic for acute coronary syndrome
764 (11.0) 361 (10.5) 403 (11.5) 0.90
Clinically diagnosed unstable angina 2402 (34.5) 1203 (34.9) 1199 (34.2) 1.03
Comorbidity or serious alternative cause 869 (12.5) 424 (12.3) 445 (12.7) 0.96
Age <25 years 444 (6.4) 238 (6.9) 206 (5.9) 1.19
Negligible risk of acute coronary syndrome 847 (12.2) 427 (12.4) 420 (12.0) 1.04
Trial specific exclusion criteria 513 (7.4) 243 (7.0) 270 (7.7) 0.91
Eligible to consent 1118 (16.1) 555 (16.1) 563 (16.1) 1.00
Papers
BMJ Online First bmj.com page 3 of 6
Figure 2 shows the cost effect pairs plotted on the cost effec-
tiveness plane.19 Each represents a bootstrap estimate of the dif-
ference in mean cost (Y axis) and mean effect (X axis) of care in
the chest pain observation unit compared with routine care
(positive values indicate that the chest pain observation unit is
more effective and more expensive). This shows that, although
care in the chest pain observation unit is very likely to be more
effective than routine care, considerable uncertainty prevails
regarding comparative costs, with the 95% confidence interval
including the possibility of the chest pain observation unit being
more expensive. However, if we are willing to pay £2750 per
QALY gained by care in the chest pain observation unit then the
probability that the chest pain observation unit will be
considered cost effective is 95%.20
Discussion
Main findings
Use of a chest pain observation unit reduced the number of
admissions to hospital and reattendance at the emergency
department, and improved health utility over the following six
months. This difference in health utility represents a 2.7%
improvement in quality of life over the six month follow up.
Although we detected no significant differences in inappropriate
discharges with acute coronary syndrome, readmissions to
hospital, or costs to the health service, in each case the point esti-
mate favoured the chest pain observation unit. Rates of major
adverse cardiac events were almost identical in the two groups.
Cost effectiveness
From an economic viewpoint, mean estimates show that the
chest pain observation unit dominates routine care by providing
improved outcomes at lower cost. Yet substantial uncertainty
surrounds the cost estimate, and the chest pain observation unit
may be more expensive. If it is more expensive it is still likely to
be considered cost effective as there is a 95% probability that the
chest pain observation unit will be cost effective, given
willingness to pay £2750 per QALY gained. This is much lower
than the value of £30 000 per QALY that seems to guide
decision making by the National Institute for Clinical
Excellence.20
Comparison with other studies
Previous studies of cost effectiveness have compared care in a
chest pain observation unit with inpatient treatment.21–23 Our
study shows that such a comparison is inappropriate because
46% of the patients receiving routine care were not admitted to
hospital. Consequently, the estimated cost savings generated by
our study were lower and subject to greater uncertainty than
previous estimates. However, by measuring the patients’ self
reported health we showed noteworthy improvements in health
utility associated with the chest pain observation unit. These data
cannot explain why health utility is improved, but the chest pain
observation unit may provide greater reassurance through a
more rigorous diagnostic work-up. If this is so the chest pain
observation unit may be justified by improving outcome, rather
than simply reducing costs.
Limitations
The use of cluster randomisation and outcome measures
assessed by patients are valuable in the evaluation of changes to
the organisation of services. In this study cluster randomisation
provided a pragmatic economic comparison of the chest pain
observation and routine care, whereas individual randomisation
would have measured the cost effectiveness of the chest pain
observation unit when managing only half the available patients.
However, these methods have some limitations. Firstly, since
randomisation takes place before recruitment and consent to
participate, it is possible for selection bias to influence results. We
attempted to reduce this possibility by rigorous recording of
selection criteria and by adjusting for known confounders in sec-
ondary analyses. This cannot, however, completely rule out the
potential influence of selection bias. Secondly, since it is impossi-
ble to blind participants to the fact that they are receiving the
chest pain observation unit or routine care, it is possible that a
measure reported by patients, such as the EQ-5D, may be influ-
enced by the patients’ awareness that they are receiving “new” or
routine care.
Implications for future research
Finally, further research is required before we can generalise the
results of this study to other hospitals. The Northern General
Table 2 Baseline characteristics of the study groups. Values are numbers
(percentages) unless otherwise indicated
Characteristic
Care in the chest pain
observation unit Routine care
Age (years) 49.4 49.6
Male sex 304 (63.5) 318 (64.5)
Known coronary heart
disease
16 (3.3) 27 (5.5)
Hypertension 127 (26.5) 120 (24.3)
Diabetes 17 (3.5) 29 (5.9)
Hyperlipidaemia 58 (12.1) 70 (14.2)
Smoker 169 (35.3) 143 (29.0)
Family history 189 (39.5) 200 (40.6)
Nature of pain
Indigestion or burning 60 (12.5) 56 (11.4)
Stabbing or sharp 116 (24.2) 113 (22.9)
Aching, dull, or heavy 175 (36.5) 181 (36.7)
Gripping or crushing 66 (13.8) 59 (12.0)
Other 57 (11.9) 71 (14.4)
Site of pain
Central 317 (66.2) 335 (68.0)
Left chest 129 (26.9) 125 (25.4)
Right chest 19 (4.0) 16 (3.2)
Other 8 (1.7) 8 (1.6)
Radiation of pain
None 183 (38.2) 189 (38.3)
Left arm 118 (24.6) 142 (28.8)
Right arm 31 (6.5) 26 (5.3)
Neck 22 (4.6) 22 (4.5)
Jaw 15 (3.1) 13 (2.6)
Back 70 (14.6) 53 (10.8)
Other 27 (5.6) 30 (6.1)
Duration of pain
Continuous pain 312 (65.1) 341 (69.2)
Intermittent pain 93 (19.4) 95 (19.3)
Other symptoms
Nausea 129 (26.9) 161 (32.7)
Vomiting 25 (5.2) 31 (6.3)
Dyspnoea 185 (38.6) 202 (41.0)
Sweating 192 (40.1) 210 (42.6)
Electrocardiogram at
presentation
Normal 412 (89.0) 382 (82.2)
Non-specific 38 (8.2) 64 (13.8)
Old change 13 (2.8) 19 (4.1)
Source of referral
Referral from general
practitioner
138 (28.8) 116 (23.5)
Self referred 173 (36.1) 155 (31.4)
999 emergency call 145 (30.3) 189 (38.3)
Other 23 (4.8) 33 (6.7)
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Hospital’s chest pain observation unit is currently unique in the
United Kingdom,24 and we do not yet know whether it can be
reproduced successfully elsewhere. Despite these limitations this
study provides the best current available evidence for the
effectiveness and cost effectiveness of the chest pain observation
unit. It shows that the chest pain observation unit has the poten-
tial to improve care and may reduce costs to the health service.
Future research should evaluate the implementation of the chest
pain observation unit and explore the development and
refinement of the chest pain observation unit protocol.
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Fig 2 Cost effectiveness plane for care in the chest pain observation unit compared with routine care based on 1000 bootstrap estimates of the difference in costs and
QALYs. The vertical and horizontal bars indicate the 95% confidence intervals for cost and effect differences. The ellipse indicates the 95% confidence interval for cost
effectiveness
What is already known on this subject
Chest pain observation units have the potential to improve
care for patients presenting with acute, undifferentiated
chest pain and reduce costs to the health service
Care in the chest pain observation unit is safe and practical,
but reliable evidence of effectiveness and cost effectiveness
is lacking
What this study adds
Care in the chest pain observation unit reduces hospital
admissions without increasing inappropriate discharges
with an acute coronary syndrome
Health utility is improved while costs to the health service
are reduced
Care in the chest pain observation unit is therefore more
effective and more cost effective than routine care
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